Results for cancer: 199

* Chemo combination trial for early-stage breast cancer * Six patients suffer congestive heart failure, no deaths * Trial participants can still take drug once informed ZURICH/BOSTON, Sept 25 - Swiss drugmaker Roche Holding AG...

RECENT RESEARCH INDICATES that dark chocolate's chemicals, which act as antioxidants, have been shown to play a role in reducing cancer risks by helping to combat cell damage that can lead to tumor growth ...

WASHINGTON, Feb 10 - A test that looks for tumor cells in the blood may make doctors better able to check whether chemotherapy is helping a prostate cancer patient, researchers reported on Tuesday. The CellSearch...

When it comes to certain types of cancer, the problem is not so much the tumor as it is the spread of cancer to other parts of the body. But now researchers are reporting a new way to inhibit this process...

* Shares surge almost 13 percent in after-hours trade * Denosumab reduces or delays bone complications * Infrequent jaw deterioration seen, similar to Zometa (Adds trial results details) NEW YORK, July 7 - Amgen Inc...

LONDON, Sept 12 - GlaxoSmithKline Plc is creating a new cancer-focused research and development group, marking a realignment of its R&D machine, the world's second largest drugmaker said on Friday. New Chief Executive Andrew Witty,...

* Had previously said would seek OK in November * Shares rise 4.8 pct NEW YORK, Nov 2 - Dendreon Corp has completed its U.S. regulatory submission for its closely watched experimental prostate cancer vaccine,...

* Withdraws Zactima plus chemo in non-small cell lung cancer * Analysis shows no overall survival benefit * Blow to pipeline, though Phase III tests will continue * Shares down 1.5 percent LONDON, Oct 28...

BOSTON, Oct 22 - Celgene Corp said on Thursday that its third-quarter earnings rose on higher sales of its blood cancer drugs. Net income rose to $217 million, or 46 cents a share, from $136.8...

NEC Corporation (NEC; TSE: 6701) announced today it has started a joint evaluation of NEC's cancer diagnosis assistance system, e-Pathologist, at Massachusetts General Hospital (Headquarters: Boston, MA, USA; President: Peter L. Slavin, MD; MGH).